Which liver diseases are associated with multiple hepatic cysts?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 22, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Liver Diseases Causing Multiple Cysts

Polycystic liver disease (PLD) is the primary condition causing multiple hepatic cysts, defined by the presence of >10 cysts, and occurs either in isolation (autosomal dominant polycystic liver disease/ADPLD) or associated with autosomal dominant polycystic kidney disease (ADPKD). 1

Primary Diseases with Multiple Hepatic Cysts

Polycystic Liver Disease (PLD)

  • Diagnostic criterion: >10 hepatic cysts 1
  • Prevalence: 1/10,000–1/158,000 1
  • Two forms:
    • ADPLD: Isolated liver involvement (at least 6 causative genes, though >50% remain genetically unexplained) 1
    • ADPKD: Combined liver and kidney cysts (mainly PKD1 and PKD2 genes) 1
  • Gender predominance: Female-to-male ratio of 3:1, with estrogen driving cyst growth 2
  • Inheritance: Autosomal dominant with 50% transmission risk 1

Caroli Disease and Caroli Syndrome

  • Caroli disease: Characterized by saccular or fusiform dilatation of intrahepatic bile ducts appearing as multiple cystic structures 1
  • Caroli syndrome: Combines bile duct dilatation with congenital hepatic fibrosis and kidney cysts, likely part of autosomal recessive polycystic kidney disease (ARPKD) spectrum 1
  • Key differentiator: Hepatic fibrosis presence separates syndrome from disease 1
  • Inheritance: Autosomal recessive (PKHD1 gene mutations) 1
  • Complications: 7% cholangiocarcinoma risk (versus 0.05% general population) 1

Biliary Hamartomas (Von Meyenburg Complexes)

  • Appearance: Multiple tiny (<1 cm) hypodense lesions scattered throughout liver 1
  • Prevalence: 5.6% in general population 1
  • Clinical significance: Typically asymptomatic, incidental findings that can mimic liver metastases 1
  • Malignant potential: Very low risk despite being found in 40% of resected cholangiocarcinoma specimens 1
  • Associated conditions: May occur with Caroli disease, congenital hepatic fibrosis, ADPKD, or ADPLD 1

Peribiliary Cysts

  • Location: Exclusively in hepatic hilum and larger portal tracts 3
  • Association: Linked to portal hypertension and cirrhosis 3
  • Clinical presentation: Generally asymptomatic, though can cause obstructive jaundice if large 3

Common Pitfalls and Caveats

Critical distinction: Multiple simple hepatic cysts scattered throughout the liver do NOT constitute PLD unless >10 cysts are present. Simple hepatic cysts are common (prevalence 2.5–18%) and typically solitary or few in number 1.

Misdiagnosis risk: Cystic bile duct hamartomas and benign biliary cysts are frequently multifocal and commonly misdiagnosed as "hepatobiliary cystadenoma" when they show degenerative or inflammatory changes 4. True mucinous cystic neoplasms (MCNs) with ovarian-type stroma are solitary in 90% of cases and constitute only 10.5% of hepatic cysts 4.

Imaging approach:

  • Ultrasound is first-line for diagnosis 1
  • MRI superior to CT for detecting small cysts, especially in young patients and those with renal insufficiency 1
  • Magnetic resonance cholangiopancreatography has highest diagnostic accuracy for Caroli disease, demonstrating continuity between cystic lesions and bile ducts 1

Surveillance considerations:

  • Asymptomatic simple cysts, biliary hamartomas, and peribiliary cysts require no follow-up 1
  • Caroli disease/syndrome may warrant annual MRCP surveillance for cholangiocarcinoma 1

References

Research

Polycystic liver diseases.

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2010

Research

Multiple hepatic peribiliary cysts with cirrhosis.

Journal of gastroenterology, 2004

Related Questions

What is the detailed interpretation and recommended management of an abdominal MRI showing a mildly enlarged liver with multiple sub‑centimeter biliary cysts, a 4.3 × 3.3 cm thin‑walled cyst in the caudate lobe, a simple 1.8 × 1.6 × 1.6 cm cyst in the pancreatic tail, normal gallbladder and bile ducts, normal pancreas, spleen, adrenal glands, and kidneys with small cortical cysts, and no evidence of obstruction, lymphadenopathy, or ascites?
Do hepatic cysts increase the risk of hepatocellular carcinoma?
In a 64-year-old woman presenting with blurred vision, dyspnea, generalized numbness, frequent urination with hematuria on urinalysis, normal complete blood count and comprehensive metabolic panel, hyperglycemia on oral glucose tolerance test, normal brain MRI, and CT abdomen/pelvis showing a 1‑cm hepatic cyst and dependent atelectasis, what is the differential diagnosis?
Can you interpret the CT scan of the lower thorax and abdomen in a 59‑year‑old patient that shows bibasilar atelectasis, hepatic steatosis with mild hepatomegaly, a 2 mm Bosniak‑type 1 renal cyst, a small umbilical fat‑containing hernia, and low‑grade chronic mesenteric panniculitis, and advise on appropriate management?
Do hepatic cysts require work‑up?
Is lamotrigine 400 mg daily an appropriate maintenance dose for a patient with bipolar I disorder, and should additional anti‑manic medication be added if mania persists?
Is screening for renal cell carcinoma recommended for the general adult population or only for high‑risk individuals?
Can prediabetes (impaired glucose tolerance) cause chronic spontaneous urticaria?
What is the appropriate management for recurrent hypoglycemia despite dextrose infusion?
How should incidentally discovered masses (incidentalomas) be evaluated and managed based on size, imaging characteristics, and patient risk factors?
What are the implications of Epstein‑Barr virus (EBV) infection in immunosuppressed patients (e.g., organ‑transplant recipients, chemotherapy patients, or those on high‑dose corticosteroids or biologic agents)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.